Displaying items by tag: comprehensive diabetes center
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
Tagged under
A gene called TXNIP was the answer, and it led to a drug called verapamil and a successful diabetes trial.
Tagged under
Inhibition of this microRNA might improve response to newer diabetes drugs, such as Byetta, Victoza, Trulicity, Januvia, Onglyza and Tradjenta.
Recruitment for the trial continues as Myers discusses the benefits she received from participating and the knowledge she has gained to take control of her health care.
Tagged under
Lead author of paper published in Diabetes Research and Clinical Practice journal says, while causal relationship cannot be inferred, findings are “absolutely encouraging.”
Tagged under
Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
Tagged under
Three-year grant establishes consortium to better organize and support collaborative research related to the loss of functional beta cell mass in type 1 diabetes.
Tagged under
Looking forward to a promising 2015, UAB News revisits some top stories of 2014.
Tagged under
- campaign for uab
- kidney chain
- office of global engagement
- cancer and radiology
- honors college
- school of medicine
- school of health professions
- school of education
- collat school of business
- school of public health
- school of nursing
- school of engineering
- abroms engel institute for the visual arts
- college of arts and sciences
- science and technology honors program
- southern research institute
- neuroscience
- center for information assurance and joint forensics research
- department of computer science
- department of criminal justice
- division of pediatric infectious diseases
- department of pediatrics
- school of optometry
- school of dentistry
- comprehensive diabetes center
- uab medicine
- department of nutrition sciences
- department of psychology
- department of anesthesiology and perioperative medicine
- alys stephens center
- artplay
- oneal comprehensive cancer center
In human clinical trial, UAB to test drug shown to completely reverse diabetes in human islets, mice
The “repurposing of verapamil as a beta cell survival therapy in type 1 diabetes” trial will test an approach different from any current diabetes treatment.
Learn more about causes, therapies and training during UAB Comprehensive Diabetes Center’s annual research day.
Tagged under
Counting carbs, exchanging candy for other treats and saving it for dessert are all alternatives for parents to consider.
Tagged under
EndoBarrier trial testing liner that forms barrier between food, portion of intestine to help obese people with uncontrolled type 2 diabetes
Tagged under
Long-term study shows weight loss improves quality of life but does not decrease cardiovascular complications in Type 2 diabetics.
Tagged under
The UAB Diabetes Research Center is part of nationwide study on benefits and risks of four widely used diabetes drugs in combination with metformin.
Tagged under
The Diabetes Research Center (DRC) focuses on developing new methods to treat, prevent and ultimately cure diabetes and its complications.
Tagged under
Intensive lifestyle interventions can put Type 2 diabetes into remission, eliminate need for medication, according to a new study.
Diabetes expert says being over supplied, preparing for security checks and anticipating time zone changes can make travelling easier and safer.
Tagged under
Carb counting and insulin pumps help diabetic kids sample Halloween’s sweet indulgences.
Tagged under
UAB’s Diabetes Bridge Clinic helps patients keep symptoms under control during the vulnerable period as they go from hospital to home.
Tagged under